Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
Status:
Completed
Trial end date:
2016-06-04
Target enrollment:
Participant gender:
Summary
RATIONALE: Abiraterone acetate may stop the growth of tumor cells by blocking some of the
enzymes needed for cell growth.
PURPOSE: This phase I/II trial is studying the side effects and best dose of abiraterone
acetate and to see how well it works in treating postmenopausal women with advanced or
metastatic breast cancer.